Bone Biologics to Begin Study of NB1 Bone Graft
The company will begin a 30-patient pilot clinical trial with NB1 in spinal fusion patients in Australia later this year. Apr 11, 2023
Update: Episurf Medical in the US Market
To support the Episealer Patellofemoral System, its first product in the region, Episurf is building a network of U.S. distributors. Apr 11, 2023
Bioventus Announces CEO Leadership Change
Ken Reali has stepped down as CEO and member of the Board of Directors. Anthony Bihl is appointed as interim CEO. Apr 06, 2023
restor3d Gains FDA 510(k) for Patient Specific Resection Guides
The all metal resection guides incorporate an engineered surface to provide added stability between guide and bone. Apr 06, 2023
First U.S. Clinical Use of ZSFab Cervical Interbody System
Prior to this first US clinical use, the ZSFab Cervical Interbody System had already been successfully implanted in clinical cases in China. Apr 06, 2023
Osteopore Enters Research Collaboration
The project will study treatment of large post-traumatic bone defects using Osteopore’s custom Polycaprolactone and Tricalcium Phosphate implant. Apr 06, 2023
Ortho Development Partners with Naviswiss on Assistive Technology
The collaboration combines Ortho Development’s hip and knee replacement implants and Naviswiss’ miniaturized hand-held navigation solutions. Apr 05, 2023
Biologica Technologies Signs Agreements with Premier and Academy Medical
The partnerships increase the company's distribution footprint and provide new avenues to accelerate growth. Apr 05, 2023
Abyrx Gains Additional FDA Clearances for MONTAGE Bone Putty
MONTAGE settable, resorbable bone putty received additional 510(k) clearances as bone void filler and cranial bone cement. Apr 05, 2023
Multicenter Study of DEXA-C Cervical Interbody
Aurora Spine has received Independent Review Board multi-site selection approval for its DEXA-C Cervical Interbody System. Apr 05, 2023
